SETBP1 and myeloid neoplasm: Since the occurrence of SETBP1 mutations has been associated with disease progression in myeloid neoplasms [2, 3], the leukemogenic capability of wild-type Setbp1 suggest that these mutations could be responsible for driving leukemic transformation of these diseases.